Heron Therapeutics reported $254.42M in Current Assets for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Arrowhead Research ARWR:US $ 417.63M 79.35M
Eisai 4523:JP Y 587057M 16340M
Immunogen IMGN:US $ 456.72M 22.03M
Nektar Therapeutics NKTR:US $ 795.58M 190.55M
Omeros OMER:US $ 210.22M 37.67M
Sangamo Biosciences SGMO:US $ 340.06M 58.7M